Our previous study showed that although BRAF or MAP2K1 alterations were present in nearly 90% of adults with LCH, unlike in pediatric patients, BRAFV600E occurred in only 31.5% of adult LCH patients, while BRAFindel was identified in 28.8% of patients [7]. Here, MAP2K1 is linked to Langerhans cell histiocytosis.